Article Text

other Versions

PDF
Langerhans Cell Histiocytosis
  1. Kevin P Windebank (k.p.windebank{at}ncl.ac.uk)
  1. Newcastle University, United Kingdom
    1. Vasanta Nanduri (v_nanduri{at}hotmail.com)
    1. Watford General Hospital, United Kingdom

      Abstract

      Langerhans Cell Histiocytosis is a rare disease. Depending on which organs are involved the disease may prove rapidly fatal, develop a chronic reactivating but therapy responsive pattern or resolve spontaneously. Understanding of the pathology of the disease is progressing rapidly and whilst clinical trials of standard chemotherapy agents continue, it is likely that novel targeted therapy will become feasible in the next decade. Permanent consequences of the disease are commoner than generally realised.

      Statistics from Altmetric.com

      Request permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.